Zobrazeno 1 - 6
of 6
pro vyhledávání: '"C D, Toseland"'
Autor:
R. E. Buckingham, K. A. Al-Barazanji, C. D. Toseland, M. Slaughter, S. C. Connor, A. West, B. Bond, N. C. Turner, J. C. Clapham
Publikováno v:
Diabetes. 47:1326-1334
Publikováno v:
Diabetes, obesitymetabolism. 3(3)
Rosiglitazone (BRL-49653-C), a thiazolidinedione, is a potent agonist for the nuclear hormone receptor peroxisome proliferator-activated receptor gamma (PPARgamma). Thiazolidinediones have been reported to induce adipocyte differentiation in vitro an
Publikováno v:
Metabolism: clinical and experimental. 49(12)
Destruction of pancreatic beta cells has been implicted in the progression to hyperglycemia in type 1 diabetes. While there is evidence of beta-cell loss in type 2 diabetes, its contribution to the development of the diabetic state is undecided. Nico
Publikováno v:
Digestive diseases and sciences. 43(1)
The therapeutic potential of urease inhibition of Helicobacter pylori has been studied by examining the effect of the potent urease inhibitor, fluorofamide (N-(diaminophosphinyl)-4-fluorobenzenamide), on urease activity and bacterial survival in vivo
Publikováno v:
European journal of rheumatology and inflammation. 14(2)
To determine the effects of nabumetone, compared with tiaprofenic acid and etodolac, on anti-inflammatory efficacy and gastrointestinal irritancy in the rat when dosed orally for one month at a high anti-inflammatory dose.Carrageenan paw edema was us
Publikováno v:
Agents and actions.
6MNA, the active metabolite of the non-acidic anti-inflammatory drug nabumetone, was investigated using intravenous administration for effects on (a) carrageenan paw oedema and gastric irritancy compared to either oral nabumetone or both oral and int